8-KOther Events

UNITEDHEALTH GROUP INC 8-K Report (May 5, 2004)

Filed May 5, 2004For Securities:UNH

Summary

UnitedHealth Group (UNH) has announced proactive measures to enhance its corporate governance and ensure director independence, aligning with evolving Institutional Shareholder Services (ISS) standards. These changes are being implemented ahead of the ISS's formal review in Fall 2004. The company is voluntarily making these adjustments to maintain the highest standards of independence for its board members and committees. This includes a director's decision to step down from the Audit Committee and a planned termination of services with a specific law firm, demonstrating UNH's commitment to robust governance practices beyond regulatory requirements.

Key Highlights

  • 1Richard T. Burke, a Director, will no longer serve on the Audit Committee effective May 5, 2004.
  • 2This action is in anticipation of Institutional Shareholder Services' (ISS) review of director independence standards in Fall 2004.
  • 3UnitedHealth Group will cease engagement with the law firm Greenbaum Doll & McDonald PLLC by June 30, 2004.
  • 4The decision to end the law firm's engagement is due to the firm's Of Counsel, William C. Ballard, Jr., also being a member of UNH's Board of Directors.
  • 5These steps are being taken to comply with current ISS standards on director independence.
  • 6UNH emphasizes that these actions go beyond existing New York Stock Exchange and SEC rules.

Frequently Asked Questions

Richard T. Burke is stepping down from the Audit Committee to align with current Institutional Shareholder Services (ISS) standards regarding director independence, pending a formal review by ISS in Fall 2004.

UnitedHealth Group is ending its engagement with Greenbaum Doll & McDonald PLLC by June 30, 2004, because a member of the law firm, William C. Ballard, Jr., is also a director on UNH's Board. This action is to ensure compliance with ISS standards for director independence.

No, these specific changes are being implemented proactively by UnitedHealth Group to conform with current ISS standards for director independence, which are in addition to the existing rules and regulations from the New York Stock Exchange and the Securities and Exchange Commission.

ISS is an independent organization that provides proxy voting and corporate governance research to institutional investors. Their standards are influential in how companies structure their boards and committees to ensure perceived and actual independence, which is crucial for investor confidence.